New Gram-positive agents in nosocomial infection

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Multidrug-resistant Gram-positive pathogens such as vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci account for a significant number of nosocomial infections, and new options for therapy have been lacking. During the past year, two agents have been released that have activity against these organisms: quinupristin/dalfopristin and linezolid. Although neither agent is a panacea, these recently released agents offer new options for therapy. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish (US)
Pages (from-to)593-598
Number of pages6
JournalCurrent Opinion in Infectious Diseases
Issue number6
StatePublished - Jan 1 2000

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'New Gram-positive agents in nosocomial infection'. Together they form a unique fingerprint.

Cite this